drugset / Trial / NCT01223625

Effect of Intensive Lipid Lowering Treatment Compared to Moderate Lipid Lowering Treatment on Endothelial Function

NCT01223625

Phase 4 Completed 87 enrolled Odense University Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

The aim of this study was to measure the effect of moderate and intensive lipid-lowering treatment with rosuvastatin on the endothelial function.

Timeline

Start
2007-11
Primary completion
2009-06
Completion
2010-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Rosuvastatin Small molecule 5 mg
Comparator Rosuvastatin Small molecule 40 mg

Indications